Site icon pharmaceutical daily

Global Oral Solid Dosage Excipients Market Research Report 2022: Independent Approval Pathway for Development of Novel Excipients will Augment Industry Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Oral Solid Dosage Excipients Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering.

The report analysis of the oral solid dosage excipients market aims at quantifying the consumption and analyzing the impact of key disruptive, transformative, and competitive trends across the value chain to present a forecast from 2022 to 2030. The study includes the analysis of the oral solid dosage excipients market based on key product types, sub-types, and geographies.

This research service analyzes the global oral solid dosage excipients market, covering North America, Europe, the Asia-Pacific (APAC), Latin America, and the Middle East & Africa (LAMEA). It details global and regional trends, market drivers and restraints and focuses on the oral solid dosage excipients used to formulate various drugs.

The study includes the oral solid dosage excipients analysis based on key product segments of binders & fillers, coatings, disintegrants, glidants & lubricants, solubilizers, surfactants & emulsifiers, and others. It further quantifies the consumption of key sub-types within each of these product segments.

Expanding patient base and the need to develop targeted and effective therapies will drive market growth in the forecast period. Demand for patient-compliant drugs, such as orally disintegrating or rapidly disintegrating drugs, specifically for the aged population, has increased. It led to a surge in demand for excipients adaptable for such drugs.

In addition, the growth in the end-use industry magnified by the trends, such as increasing chronic illnesses, rapidly aging population coupled with rising healthcare spending, and growing demand for multifunctional excipients, are estimated to drive market growth in the near future.

On the other hand, with an increasing number of pharmaceutical formulators using technologies to improve drug manufacturing efficiency, such as continuous manufacturing instead of batch manufacturing, the need for novel excipients is expected to rise over the forecast period.

The oral solid dosage excipients market has various global and regional participants. Companies focus on organic and inorganic growth strategies, with the expansion of product portfolios across geographies being a key growth strategy. Expanding the co-processed and multifunctional excipients portfolio remains a key area of focus.

Key Topics Covered:

1. Strategic Imperatives

2. Growth Opportunity Analysis – Oral Solid Dosage Excipients

3. Growth Opportunity Analysis – Oral Solid Dosage Excipients

4. Growth Opportunity Analysis – Binders & Fillers

5. Growth Opportunity Analysis – Coatings

6. Growth Opportunity Analysis – Disintegrants

7. Growth Opportunity Analysis – Glidants & Lubricants

8. Growth Opportunity Analysis – Solubilizers, Surfactants, and Emulsifiers

9. Growth Opportunity Analysis – Others

10. Growth Opportunity Universe

11. Next Steps

For more information about this report visit https://www.researchandmarkets.com/r/p1si75

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version